Soleno Therapeutics (SLNO) Other Non Operating Income (2016 - 2017)
Historic Other Non Operating Income for Soleno Therapeutics (SLNO) over the last 5 years, with Q4 2017 value amounting to $5000.0.
- Soleno Therapeutics' Other Non Operating Income fell 9878.49% to $5000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$752000.0, marking a year-over-year decrease of 14686.83%. This contributed to the annual value of -$62000.0 for FY2018, which is 8949.15% up from last year.
- Soleno Therapeutics' Other Non Operating Income amounted to $5000.0 in Q4 2017, which was down 9878.49% from $3000.0 recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' Other Non Operating Income registered a high of $4.9 million during Q2 2015, and its lowest value of -$9.2 million during Q1 2015.
- For the 5-year period, Soleno Therapeutics' Other Non Operating Income averaged around -$415041.3, with its median value being -$49000.0 (2013).
- Over the last 5 years, Soleno Therapeutics' Other Non Operating Income had its largest YoY gain of 43142.66% in 2015, and its largest YoY loss of 11521250.0% in 2015.
- Over the past 5 years, Soleno Therapeutics' Other Non Operating Income (Quarter) stood at -$104965.0 in 2013, then plummeted by 1691.53% to -$1.9 million in 2014, then skyrocketed by 135.21% to $662200.0 in 2015, then crashed by 37.86% to $411497.0 in 2016, then plummeted by 98.78% to $5000.0 in 2017.
- Its last three reported values are $5000.0 in Q4 2017, $3000.0 for Q3 2017, and -$88000.0 during Q2 2017.